Regulatory officials have identified 82 cases worldwide from the FDA Adverse Event Reporting System of anaphylaxis associated ...
The FDA added a boxed warning about rare cases of anaphylaxis associated with the multiple sclerosis (MS) drug glatiramer ...
Reports of anaphylaxis associated with the use of glatiramer acetate have prompted the Food and Drug Administration (FDA) to add a Boxed Warning to the prescribing information.
The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with ma ...
A popular corn puff snack has been recalled for not listing milk as an allergen on the package.
The U.S. Supreme Court appeared skeptical Tuesday of the government's attempt to limit the number of Food and Drug ...
The Supreme Court will hear oral arguments on Tuesday in a clash over whether a North Carolina-based company can challenge the Food and Drug Administration’s denial of its application to market ...
The Trump administration’s food regulatory agenda will come into sharper focus once nominees for the U.S. Department of Health and Human ...
Following an extensive scientific review, the U.S. Food and Drug Administration has authorized the marketing of 20 ZYN ...
Federal officials on Wednesday released a far-reaching proposal to make cigarettes far less addictive by capping their ...
Federal health officials on Thursday backed the public health benefits of nicotine pouches, authorizing Philip Morris ...
Rese-cel, previously called CABA-201, is a CAR T-cell therapy that's designed to treat MS by depleting B-cells.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback